Bharat Biotech is a renowned biotechnology company at the forefront of innovation in India. With over 25 years of experience, they are leaders in the production of vaccines and bio-therapeutics, focusing on diseases like Rotavirus, Hepatitis-B, Typhoid, Polio, Diphtheria, Measles, Influenza, and Rabies. Their cutting-edge research has led to breakthroughs in the field, enabling patients to overcome challenging diseases.

Committed to affordability, safety, and quality, Bharat Biotech aims to provide accessible healthcare solutions. They prioritize emerging markets and continuously strive to revolutionize biotechnology by delivering world-class products. Bharat Biotech's product portfolio includes a wide range of innovative vaccines such as COVAXIN®, Rotavac, and Typbar TCV.

These are complemented by their bio-therapeutics line, including Biogit, Regen-D, and SLVRGEN. Through their dedication to clinical research, manufacturing capabilities, and strategic partnerships, Bharat Biotech has established itself as a global leader in the biotechnology industry. With a mission to empower individuals to lead healthier lives, Bharat Biotech is unwavering in their commitment to deliver high-quality, affordable solutions that make a significant impact on public health worldwide